D R Dufour

Summary

Country: USA

Publications

  1. ncbi Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests
    D R Dufour
    Pathology and Laboratory Medicine Service, Veterans Affairs Medical Center, Washington, DC 20422, USA
    Clin Chem 46:2027-49. 2000
  2. ncbi Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring
    D R Dufour
    Pathology and Laboratory Medicine Service, Veterans Affairs Medical Center, Washington, DC 20422, USA
    Clin Chem 46:2050-68. 2000
  3. ncbi Low-positive anti-hepatitis C virus enzyme immunoassay results: an important predictor of low likelihood of hepatitis C infection
    D Robert Dufour
    Pathology and Laboratory Medicine Service, Veterans Affairs Medical Center, Washington, DC 20422, USA
    Clin Chem 49:479-86. 2003
  4. ncbi Chemiluminescence assay improves specificity of hepatitis C antibody detection
    D Robert Dufour
    Pathology and Laboratory Medicine Service, Veterans Affairs Medical Center and Department of Pathology, The George Washington University Medical Center, Washington, DC, USA
    Clin Chem 49:940-4. 2003
  5. ncbi Lot-to-lot variation in anti-hepatitis C signal-to-cutoff ratio
    D Robert Dufour
    Pathology and Laboratory Medicine Service, Veterans Affairs Medical Center, Washington, DC 20422, USA
    Clin Chem 50:958-60. 2004
  6. ncbi Hepatitis B surface antigen (HBsAg) assays--are they good enough for their current uses?
    D Robert Dufour
    Clin Chem 52:1457-9. 2006
  7. ncbi Cost effectiveness of testing strategies for chronic hepatitis C
    Michael K Chapko
    Northwest Hepatitis C Resource Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA
    Am J Gastroenterol 100:607-15. 2005
  8. ncbi Sodium-wasting nephropathy caused by cisplatin in a patient with small-cell lung cancer
    Akila V Iyer
    Veterans Affairs Medical Center, Washington, DC 20422, USA
    Clin Lung Cancer 5:187-9. 2003
  9. ncbi Laboratory approach to acute and chronic hepatitis
    D Robert Dufour
    Laboratory Medicine Service, Veterans Affairs Medical Center, Washington, DC, USA
    MLO Med Lab Obs 35:10-2, 14, 16; quiz 20-1. 2003
  10. ncbi Laboratory tests of thyroid function: uses and limitations
    D Robert Dufour
    Pathology and Laboratory Medicine Service, Veterans Affairs Medical Center, and George Washington University Medical Center, 2300 Eye Street, NW, Washington, DC 20037, USA
    Endocrinol Metab Clin North Am 36:579-94, v. 2007

Collaborators

Detail Information

Publications10

  1. ncbi Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests
    D R Dufour
    Pathology and Laboratory Medicine Service, Veterans Affairs Medical Center, Washington, DC 20422, USA
    Clin Chem 46:2027-49. 2000
    ..Harmonization is needed for alanine aminotransferase activity, and improved standardization for hepatitis C viral RNA measurements...
  2. ncbi Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring
    D R Dufour
    Pathology and Laboratory Medicine Service, Veterans Affairs Medical Center, Washington, DC 20422, USA
    Clin Chem 46:2050-68. 2000
    ..Specific tests of viral markers should be the initial differential tests in both acute and chronic hepatic injury; when positive, they are also useful for monitoring recovery from hepatitis B and C...
  3. ncbi Low-positive anti-hepatitis C virus enzyme immunoassay results: an important predictor of low likelihood of hepatitis C infection
    D Robert Dufour
    Pathology and Laboratory Medicine Service, Veterans Affairs Medical Center, Washington, DC 20422, USA
    Clin Chem 49:479-86. 2003
    ..Several studies, mainly in blood donors, have found that specimens with low signal/cutoff (S/C) ratios are commonly negative when tested with a recombinant immunoblot assay (RIBA) or for HCV RNA...
  4. ncbi Chemiluminescence assay improves specificity of hepatitis C antibody detection
    D Robert Dufour
    Pathology and Laboratory Medicine Service, Veterans Affairs Medical Center and Department of Pathology, The George Washington University Medical Center, Washington, DC, USA
    Clin Chem 49:940-4. 2003
    ..Antibodies to hepatitis C virus (anti-HCV) have typically been detected by enzyme immunoassay (EIA). A chemiluminescence assay (CA) for anti-HCV is now commercially available...
  5. ncbi Lot-to-lot variation in anti-hepatitis C signal-to-cutoff ratio
    D Robert Dufour
    Pathology and Laboratory Medicine Service, Veterans Affairs Medical Center, Washington, DC 20422, USA
    Clin Chem 50:958-60. 2004
  6. ncbi Hepatitis B surface antigen (HBsAg) assays--are they good enough for their current uses?
    D Robert Dufour
    Clin Chem 52:1457-9. 2006
  7. ncbi Cost effectiveness of testing strategies for chronic hepatitis C
    Michael K Chapko
    Northwest Hepatitis C Resource Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA
    Am J Gastroenterol 100:607-15. 2005
    ..Our analysis makes explicit the magnitude of this trade-off...
  8. ncbi Sodium-wasting nephropathy caused by cisplatin in a patient with small-cell lung cancer
    Akila V Iyer
    Veterans Affairs Medical Center, Washington, DC 20422, USA
    Clin Lung Cancer 5:187-9. 2003
    ..Appropriate attention to the evaluation of hyponatremia following platinum-based chemotherapy is needed to properly treat these conditions...
  9. ncbi Laboratory approach to acute and chronic hepatitis
    D Robert Dufour
    Laboratory Medicine Service, Veterans Affairs Medical Center, Washington, DC, USA
    MLO Med Lab Obs 35:10-2, 14, 16; quiz 20-1. 2003
  10. ncbi Laboratory tests of thyroid function: uses and limitations
    D Robert Dufour
    Pathology and Laboratory Medicine Service, Veterans Affairs Medical Center, and George Washington University Medical Center, 2300 Eye Street, NW, Washington, DC 20037, USA
    Endocrinol Metab Clin North Am 36:579-94, v. 2007
    ....